Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
FDA Approves New Regulations for Enhanced Oversight of Clinical Trials
The FDA has introduced new regulations focused on enhancing oversight and improving the integrity of clinical trials....
Pfizer and BioNTech Collaborate on New mRNA Vaccine for Rare Diseases
Pfizer and BioNTech have launched a collaboration aimed at developing an innovative mRNA vaccine targeting rare diseases....
Novartis Receives FDA Approval for Innovative Biosimilar Drug
Novartis has received FDA approval for a new biosimilar product, expanding its portfolio in the biologics market....
Pfizer Partners with BioNTech to Accelerate mRNA Cancer Vaccine Development
Pfizer and BioNTech expand their partnership to enhance the development of mRNA technology for cancer immunotherapy....
Moderna Expands mRNA Technology for Infectious Diseases and Rare Genetic Disorders
Moderna announces an expansion of its mRNA technology platform to focus on infectious diseases and rare genetic disorders....
Pfizer and BioNTech Advance mRNA Cancer Vaccine with New Clinical Trials
Pfizer and BioNTech initiate groundbreaking clinical trials for a new mRNA-based cancer vaccine aimed at treating various oncology indications....
D3 Bio Secures FDA Breakthrough Therapy Designation for KRAS G12C Cancer Drug
D3 Bio, Inc., a clinical-stage biotechnology company focused on precision oncology, has received Breakthrough Therapy Designation and Orphan Drug Designation from the US Food and Drug Administration (FDA)...
Ifinatamab Deruxtecan Receives FDA Breakthrough Therapy Status for Lung Cancer
The U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to ifinatamab deruxtecan (I-DXd) for patients with extensive-stage small cell lung cancer (ES-SCLC) who no longer respond to platinum-based chemotherapy....
Creative Medical Gains FDA Fast Track Status for CELZ-201-DDT in Chronic Lower Back Pain
Creative Medical Technology Holdings, Inc. has announced that its lead candidate, CELZ-201-DDT, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of degenerative disc disease...
Dyne Therapeutics’ DYNE-251 Receives FDA Breakthrough Therapy Designation
Dyne Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to DYNE-251 for Duchenne muscular dystrophy (DMD) patients amenable...
